NorthRock Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Buy |
2,745
+163
| +6% | +$42.1K | 0.02% | 312 |
|
|
2025
Q1 | $578K | Buy |
2,582
+132
| +5% | +$29.5K | 0.02% | 314 |
|
|
2024
Q4 | $560K | Sell |
2,450
-682
| -22% | -$156K | 0.02% | 327 |
|
|
2024
Q3 | $765K | Sell |
3,132
-47
| -1% | -$11.5K | 0.03% | 258 |
|
|
2024
Q2 | $609K | Buy |
3,179
+322
| +11% | +$61.6K | 0.02% | 295 |
|
|
2024
Q1 | $566K | Buy |
2,857
+55
| +2% | +$10.9K | 0.02% | 325 |
|
|
2023
Q4 | $482K | Buy |
2,802
+1,328
| +90% | +$228K | 0.02% | 328 |
|
|
2023
Q3 | $218K | Buy |
1,474
+467
| +46% | +$69.1K | 0.02% | 314 |
|
|
2023
Q2 | $220K | Sell |
1,007
-159
| -14% | -$34.7K | 0.02% | 275 |
|
|
2023
Q1 | $255K | Sell |
1,166
-41
| -3% | -$8.98K | 0.03% | 261 |
|
|
2022
Q4 | $251K | Sell |
1,207
-109
| -8% | -$22.7K | 0.03% | 285 |
|
|
2022
Q3 | $287K | Buy |
1,316
+152
| +13% | +$33.1K | 0.03% | 210 |
|
|
2022
Q2 | $244K | Buy |
1,164
+255
| +28% | +$53.5K | 0.03% | 258 |
|
|
2022
Q1 | $220K | Buy |
909
+126
| +16% | +$30.5K | 0.02% | 303 |
|
|
2021
Q4 | $204K | Buy |
783
+15
| +2% | +$3.91K | 0.02% | 316 |
|
|
2021
Q3 | $202K | Buy |
+768
| New | +$202K | 0.02% | 269 |
|
|
2020
Q3 | – | Sell |
-1,042
| Closed | -$200K | – | 233 |
|
|
2020
Q2 | $200K | Buy |
+1,042
| New | +$200K | 0.02% | 201 |
|
|
2020
Q1 | – | Sell |
-1,555
| Closed | -$241K | – | 265 |
|
|
2019
Q4 | $241K | Buy |
1,555
+45
| +3% | +$6.97K | 0.03% | 230 |
|
|
2019
Q3 | $204K | Buy |
+1,510
| New | +$204K | 0.03% | 198 |
|